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ABSTRACT 
Background 
Infusible DMARDs are commonly prescribed in rheumatology and other fields. There are no 
published formal educational curricula rheumatology fellowship programs can use to teach 
infusion reaction management skills to fellows.  We aimed to better understand this 
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educational gap, and implement and assess the effectiveness of an experiential curriculum 
on acute infusion reaction management. 
  
Methods 
We included current rheumatology fellows and recent graduates from five fellowship 
programs.  Using a novel behavioral checklist we assessed fellows’ performance managing 
an infusion reaction in a simulation, followed by a didactic focused on infusion reactions.  
Pre and post-surveys assessed experiences to determine relevance, as well as attitudes and 
knowledge.  
 
Results 
Despite ubiquitous prescribing of infusible biologic DMARDs, >50% of fellows were 
uncomfortable managing infusion reactions.  Only 11% of fellows reported infusion reaction 
training during fellowship, but 56% reported managing actual patient infusion reactions.  In 
the simulated infusion reaction, fellows managed grade 1 reactions appropriately, but grade 
4 reactions poorly, meeting <50% of objectives.  All fellows discontinued the infusion in the 
setting of anaphylaxis, but only 56% administered epinephrine.  There was no difference in 
performance or written knowledge by training year.  All fellows felt more prepared to 
manage infusion reactions post-curriculum and were satisfied with the experience. 
 
Conclusion 
We confirmed an education gap in rheumatology fellowship training regarding infusion 
reactions, both in knowledge and performance.  We developed and implemented a brief 
experiential curriculum including simulation of a high-risk patient care scenario.  This 
curriculum was well received and is easily exportable to other programs. 
 
SIGNIFICANCE AND INNOVATIONS 
1. This is the first report of an educational curriculum on acute infusion reactions for 
fellows in any medicine field. 
2. Only 11% of surveyed rheumatology fellows in the collaborative received training on 
the management of infusion reactions during fellowship. 
3. Among fellows, practical knowledge about how to manage an infusion reaction was 
poor, with only half of fellows ordering epinephrine to manage a simulated grade 4 
infusion reaction, indicating either knowledge deficiencies or failure of recognition. 
4. As infusible biologic medications are becoming more common, this brief, intensive 
curriculum can be easily implemented in other fields of medicine. 
 
INTRODUCTION 
Biologic disease-modifying anti-rheumatic drugs (DMARDs), which target disease specific 
pathways, are commonly prescribed to manage rheumatic diseases.  All biologic DMARDS 
have the potential to cause serious adverse effects including injection site reactions (ISRs) 
and infusion reactions.  Up to 30% of patients in clinical trials of injectable DMARDS 
This article is protected by copyright. All rights reserved. 
experience ISRs (1).  Infusion reactions are also common, affecting nearly 10% of patients 
receiving infliximab, with an incidence of 6.1% (2).  Reported rates are as high as 45% with 
pegloticase in phase 3 clinical trials (3).  As learning to appropriately “prescribe, monitor and 
assess response to pharmacotherapy, including immunomodulatory agents” is a core 
competency of rheumatology fellowship training, it seems infusion therapy management 
would be a part of all fellowship curricula (4, 5).  However, informal surveying of 
rheumatology program directors from the Carolinas Fellows Collaborative (CFC) revealed no 
formalized curricula.  To date there are no published educational curricula for rheumatology 
providers addressing infusion reaction management.  Furthermore, there are no published 
studies of how often rheumatology fellows, practicing rheumatologists or physicians from 
other fields who prescribe infusion medications manage infusion reactions. 
 
Based on lack of formal education about this topic, we hypothesized current rheumatology 
fellows’ knowledge about infusion reactions would be poor.  We also assumed 
rheumatology fellows and recent graduates would agree infusion reaction management 
should be taught because of the high potential for morbidity to patients.  To address this 
potential education gap, we developed and implemented a brief and intensive educational 
curriculum that included a needs assessment survey, a practical simulation with immediate 
corrective feedback and an instructive didactic to summarize the topic.  We then collected 
feedback about this experiential curriculum.  Finally, we assessed practice patterns with 
infusible DMARDs and experiences managing infusion reactions. 
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MATERIALS AND METHODS 
The Duke University Institutional Review Board determined this study exempt from review. 
Study population.  We included current rheumatology fellows and recent (2015-2016) 
graduates from five programs:  Duke University, Wake Forest University, the University of 
North Carolina at Chapel Hill, Medical University of South Carolina and Massachusetts 
General Hospital.  These fellows attended the annual CFC Winter Conference at Duke in 
2017, during which one half-day is dedicated to performance assessment and feedback 
through a multiple station objective structured clinical examination (OSCE).   
Pre-curriculum Assessment.  A pre-survey assessed prior experience, attitudes and 
knowledge about infusion reactions.  Attitudes and comfort with management were 
measured by Likert scale.  Knowledge questions included symptom/sign reaction grading 
(defined by the National Cancer Institute Terminology Criteria for Adverse Events [NCI-
CTCAE]) and infusion management decisions by reaction grade (6).  Twenty-two fellows 
were emailed a Qualtrics© (Provo, Utah) link to the pre-curriculum survey.  Graduates were 
emailed a link to a similar survey omitting the knowledge assessment in an attempt to 
shorten the survey and improve participation. 
Simulation-based Assessment.  One week pre-conference, fellows received brief 
descriptions of the OSCE, describing one station as “Infusion:  You will speak with an 
infusion center nurse regarding patient management.”  This station simulated the 
experience of an on-call rheumatologist, paged by an infusion center nurse about a patient 
having an acute infusion reaction to a biologic DMARD.  The station was proctored by 
phone, with an allotted time of 12-minutes, followed by 3-minutes of face-to-face feedback.  
This station began with the fellow managing a patient having a grade 1 infusion reaction, 
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which evolved into a grade 4 infusion reaction.  Proctors assessed performance using a 
behavior checklist.   
 
The station scenario and performance checklist were developed based on published reports, 
local infusion center protocols and NCI-CTCAE reaction grading (6-12).  The checklist 
included three sections with a maximum score of 24 points (1 point/item):  History taking 
(10 points), Grade 1 reaction management (4 points) and Grade 4 reaction management (10 
points).   
 
Curriculum and Post-Survey.  The day following the OSCE, fellows attended a 15-minute 
interactive didactic session.  Session objectives were 1) differentiate immediate versus non-
immediate drug hypersensitivity reactions (DHRs), 2) teach the pathophysiology of DHRs, 3) 
compare and contrast anaphylactoid reactions versus anaphylaxis, 4) define the NCI-CTCAE 
grading schema and 5) teach appropriate initial assessment and management of infusion 
reactions.  Session attendees completed a post-survey again assessing attitudes, comfort 
and knowledge about infusion reactions.  
 
Statistical analysis.  Descriptive statistics were used for demographics and prior experience.  
Fischer’s exact test estimated differences in attitude and comfort Likert scale responses, 
OSCE performance by fellowship training year (year 1 compared to years 2 & 3) and 
knowledge matching questions.  Likert scale responses were grouped into categories of 
“Agree” and “Disagree.”  A two-sided t-test of the means was used for determination of 
differences between fellowship training years on the overall OSCE performance scores.  All 
analyses were conducted in SAS 9.4 (Cary, North Carolina).  
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RESULTS 
Demographics.  Eighteen rheumatology fellows completed the pre-survey:  15 (83%) adult, 
1 (6%) pediatric and 2 (11%) combined adult/pediatric rheumatology.  Respondents 
included 8 first years and 10 second year of training or beyond.  Eighteen adult 
rheumatology fellows participated in the OSCE:  8 first, 9 second and 1 third year.  Twenty-
two fellows (9 first, 9 second, 3 third and 1 fourth year) attended the didactic session and 21 
completed the post-curriculum survey.   
Surveys were emailed to 25 CFC adult rheumatology graduates.  Ten (40%) completed the 
survey: 7 graduated in 2015 and 3 in 2016.  Nine of 10 respondents were actively practicing 
rheumatology:  4 (45%) described their practice as a multi-specialty private practice, 2 (22%) 
as single specialty, 1 (11%) as solo practice, 1 (11%) as academic health center and 1 (11%) 
as hospital based.  
Attitudes, Comfort, and Experience with Infusion Reactions.  The attitude of nearly all 
fellows both before and after this curriculum, and of all graduates, was that the topic of 
acute infusion reactions is important to learn (Table 1).  Most (15 [83%]) fellows and 
graduates (9 [90%]) disagreed that acute infusion reaction management was “the job of the 
infusion service provider and not my responsibility.”  All graduates recommended current 
fellows be taught how to manage acute infusion reactions.  Reasons given included: “We are 
usually responsible for managing infusion reactions,” “Applicable to any fellow regardless of 
future career path,” “We prescribe them, we should be able to manage the reaction,” and 
“Knowledge of management is imperative if you are prescribing these drugs, especially in 
your clinic site, I feel my rheumatology training was lacking in this aspect.”  Pre-curriculum, 
11 (61%) fellows agreed their “knowledge is poor in the management of acute infusion 
reactions.” 
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Regarding comfort, 8 (44%) current fellows reported feeling comfortable managing infusion 
reactions; of the 7 fellows physically involved in such a situation, 3 (43%) were 
uncomfortable with their ability to manage the reaction.  Surveyed post-curriculum, all 
fellows answered they felt comfortable managing an infusion reaction.   All 10 graduates 
reported feeling comfortable with their ability to manage a patient with an acute infusion 
reaction.  All respondents reported a preference for prescribing subcutaneous biologic 
DMARDS over IV therapies (Table 2).  Two (11%) fellows on the pre- and 5 (24%) on the 
post-survey, along with 2 (20%) graduates, agreed this preference was due to concerns 
about their ability to manage an acute infusion reaction. 
 
Practice patterns among fellows and graduates differ.  While all respondents reported 
prescribing intravenous (IV) medications to treat rheumatic diseases, graduates (nearly all in 
private practice) primarily infuse DMARDs within the immediate clinic area, while fellows 
use a variety of infusion services (supplemental). Over half of graduates reported <10% of 
their patients were receiving infusion medications, while more than half of current fellows 
estimated 10-25% of their patients were receiving infusible medications.  Though both 
groups prescribed many different medications, all current fellows and only half of graduates 
prescribed cyclophosphamide.  
Regarding experience with infusion reactions (Table 2), few current fellows reported 
education/training prior to (3 [17%]) or during (2 [11%]) fellowship.  Half of this reported 
training was informal advice from supervising physicians.   Six (60%) graduates reported 
their training included education about infusion reactions; 3 (50%) recalled dedicated 
lectures and 2 (33%) cited presentations during training program orientation.  Despite 
minimal training, 10 (56%) fellows reported being paged and 7 (39%) had physically been 
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involved in managing a patient having an acute infusion reaction; 3 (17%) felt direct harm 
was sustained by a patient.  Four (40%) graduates reported managing a patient during 
fellowship and 5 (50%) in current practice for an acute infusion reaction; all reported 
multiple occurrences.  
 
Knowledge Assessment.  OSCE performance did not vary by training year (Table 3).  Fellows 
reliably requested the patient’s vital signs, examination findings and infusion pre-
medications.  For the grade I reaction, no fellows discontinued the infusion; 15 (83%) 
recommended decreasing the infusion rate and 15 (83%) prescribed antihistamines.  All 
fellows’ performance was highest managing the grade 1 infusion reaction, with a mean 
score of 3.3 (of 4) points.  The overall mean performance in history taking was 4.1 (of 10) 
and grade 4 infusion reaction management was 4.3 (of 10).  
 
During the grade 4 reaction simulation, all fellows appropriately discontinued the infusion.  
Most fellows activated the emergency response system and ordered continuous non-
invasive hemodynamic monitoring.  There was a non-significant higher rate of upper level 
fellows providing transition of care to EMS/ED providers and updating the patient’s 
emergency contact.  No fellow spontaneously asked the nurse to add the medication to the 
patient’s allergy list, nor did any fellow mention contacting the prescribing rheumatologist.  
Ten (56%) fellows appropriately ordered epinephrine for the grade 4 reaction (anaphylaxis).  
Inappropriate management was recommended by many fellows, with 13 (72%) ordering 
steroids and 10 (56%) ordering antihistamines.  
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In the pre-didactic knowledge assessment (supplemental), current fellows demonstrated a 
generally poor understanding of NCI-CTCAE infusion reaction grading through their inability 
to correctly match signs and symptoms to the correct reaction grade.  However, when given 
an infusion reaction grade and asked to determine if they would 1) continue, 2) decrease 
the rate or 3) stop the infusion, most fellows chose the correct management option, except 
in grade 3 in which only 55% chose correctly (discontinue the infusion).  There was no 
statistical difference in performance by training years. 
 
After the OSCE and didactic presentation, all fellows performed similarly on the post-
intervention knowledge assessment.  Eleven (52%) fellows correctly identified anaphylactoid 
reactions as the most common infusion reaction cause and all recognized the importance of 
prolonged monitoring for a grade 4 reaction.  Only 1 (5%) fellow matched a grade 3 reaction 
clinical scenario correctly.  All fellows recognized epinephrine as important in the 
management of anaphylaxis.  Four (18%) fellows answered acetaminophen and 7 (32%) 
antihistamines as important in the management of anaphylaxis. 
 
Curriculum Evaluation.  All participants rated their overall experience as being somewhat or 
extremely satisfied.  All fellows agreed their knowledge about the management of acute 
infusion reactions had improved, their awareness of IV medication related adverse effects 
had increased and the training was important and worth their effort.  Eight (38%) fellows 
answered they plan on prescribing IV DMARDs more based on information learned from the 
curriculum.   
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DISCUSSION 
We created and tested an easily transferrable educational curriculum on acute infusion 
reactions.  We confirmed a gap in training, with minimal formal education about acute 
infusion reactions prior to or during fellowship.  Nonetheless, most current fellows had been 
called to manage infusion reactions, and nearly half reported feeling uncomfortable with 
their ability to manage these patients.  Poor OSCE performance confirmed that fellows 
should feel uncomfortable managing infusion reactions, since their average score was only 
4.3/10 in simulated management of a grade 4 infusion reaction.   These findings are 
concerning, since most graduates who enter private practice can expect an office-based 
infusion center.  Of interest, while this sample of recent graduates reported comfort 
managing infusion reactions, all reported a preference for subcutaneous DMARDs and 
nearly 20% related this preference to their discomfort managing infusion reactions.  
Certainly, though, the ultimate decision on biologic formulation is not made in isolation, 
considering factors including disease-activity, cost/insurance coverage, patient preference, 
convenience, co-morbid risk factors and current/prior medications. 
 
This brief experiential curriculum is grounded in assumptions of several adult-learning 
theories. As per Knowles’ assumptions, we established curriculum relevance, setting the 
stage prior to delivery through a survey requiring fellows to reflect on their comfort with the 
topic and a brief knowledge assessment to highlight their own learning needs.  Fellows were 
notified they would face a simulated infusion reaction situation, giving them opportunity to 
pre-read about infusion reactions.  The simulated event took place during an annual 
conference, when fellows were “in the mode” of learning, consistent with the Theory of 
Margin.  Finally, experiential learning through an OSCE followed by a didactic with high-
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quality information for managing a future, similar situation, is consistent with Jarvis’ theory 
of transformational learning (13).    
 
We identified differences between written knowledge and clinical performance.  While most 
fellows correctly matched infusion reaction grade with appropriate management decisions, 
grade 4 reaction management was poor on the OSCE.  All fellows appropriately recognized 
the need to discontinue an infusion for a severe infusion reaction, but only 56% 
recommended epinephrine for anaphylaxis, suggesting either limited anaphylaxis 
recognition or inadequate management knowledge. Prior studies have shown poor 
recognition and management of anaphylaxis in other specialties (14, 15).  We presume 
fellows had not previously learned about the NCI-CTCAE grading system for infusion 
reactions, although their gestalt regarding whether to discontinue an infusion was generally 
correct.  Learning the NCI-CTCAE grading system provides a foundation for gauging the 
severity of and appropriately managing acute infusion reactions, promoting favorable 
outcomes.    
 
Limitations of this study include the use of not yet validated tools to assess knowledge and 
OSCE performance (none currently exist) and small sample size.  Additionally, survey and 
knowledge assessments were anonymous, preventing correlation of confidence with 
competence for individual fellows.  Since this was the initial implementation of this 
curriculum, determining improved knowledge during fellowship was not possible.  
Graduates reported a higher rate of training/education during fellowship compared to 
current fellows.  We are not aware of any substantial curricular changes within the 5 
fellowship programs and attribute this difference to the possibility of recall bias, sampling 
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bias and individual fellow interest as well as experience gained in practice after fellowship 
training. 
 
Study strengths include representation of fellows from multiple institutions, varied training 
years and types.  The use of multiple assessments through surveys, written testing and 
simulation also represent strengths.  Additionally, this form of curriculum is unique in that a 
practical assessment of ability was performed before the formal curriculum, to provide 
context, and it simulated a very high-risk clinical scenario without putting patients at risk.   
 
Post-knowledge testing revealed opportunity for curriculum improvement.  For example, 
only about 50% of fellows distinguished anaphylaxis from anaphylactoid reactions and only 
1 correctly recognized a grade 3 reaction based on written scenarios.  Future iterations can 
place more emphasis on reaction grade assessment and distinguishing between DHR types.  
Recording the didactic session will make it usable by other programs. 
 
In summary, we successfully developed and implemented an acute infusion reaction 
educational curriculum for rheumatology fellows, meeting an important educational need 
for safe future practice.  All participants felt this topic was important, some graduates 
commented they wished their training programs had provided this education.  As a 
rheumatologist, management of both rheumatic disease and medication related adverse 
effects are critical to patient care.  This curriculum can easily be implemented by any 
training program, with the ability to simulate a high-risk clinical scenario by phone.  With the 
exploding use of targeted biologic infusion therapies in multiple fields, this curriculum can 
be widely adapted for multiple specialties.   
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TABLES 
See attachments 
LEGENDS 
Table 1 
*1/21 (4.8%) responded as not applicable 
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†1/21 (4.8%) responded as not applicable 
ⱡ1/10 (10%) responded as not applicable 
Table 2 
*”Residency lecture,” “from senior resident” 
†Institutional GME training, “advice from 2 attendings” – reported little to moderate 
amount of influence 
ⱡ6/7 reported 2 or more times (85%); 1/7 reported more than 10 incidents 
§None resulted in death 
¶3/18 (16.7%) had concerns about their ability to manage an infusion reaction affecting 
preference 
#2/6 during fellowship orientation, 3/6 general academic lecture, 1/6 dedicated conference 
course, 2/6 other - “from rheumatology attending I worked with” and “preceptor bringing 
me along when called to manage an infusion reaction” 
**5/5 reported between 2-10 incidents per graduate 
††2/10 had concerns about their ability to manage an infusion reaction affecting preference 
Table 3 
*Most common rate reduction was by 50% 
 
 
SUPPLEMENTARY MATERIAL 
See attachments 
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Table 1.  Surveyed attitudes, comfort and self-reported knowledge of rheumatology fellows and graduates. 
 Fellow 
Pre-Survey  
Fellow  
Post-Survey 
Graduate   
Survey 
Agree 
n =18 (%) 
Agree 
n=21  (%) 
Agree 
n=10  (%) 
A
tt
it
u
d
es
 
Having a working knowledge on the assessment of an acute infusion reaction 
is important to me. 
17  (94.4) 21  (100) 10  (100) 
As a rheumatologist, I should be able to manage a patient having an acute 
infusion reaction from a DMARD. 
18  (100) 21  (100) 9ⱡ  (100) 
The management of an acute infusion reaction is the job of the infusion 
service provider and not my responsibility. 
3  (16.7) 5  (23.8) n/a 
I plan on prescribing IV DMARDs more based on what I learned from this 
curriculum. 
n/a 8*  (38.1) n/a 
This training was worth my time and effort. n/a 21  (100) n/a 
C
o
m
fo
rt
 I am uncomfortable with managing an acute infusion reaction. 10  (55.6) n/a n/a 
I am comfortable managing an acute infusion reaction. n/a 21  (100) 10  (100) 
I prefer to prescribe SQ over IV medications because I am uncomfortable 
with managing an acute infusion reaction. 
2  (11.1) 5†  (23.8) 2  (20) 
K
n
o
w
l
ed
ge
 My knowledge is poor in the management of acute infusion reactions. 11  (61.1) n/a n/a 
My knowledge about acute infusion reactions is improved. n/a 21  (100) n/a 
I am more aware of IV medication related adverse effects. n/a 21  (100) n/a 
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Table 2.  Reported prior education, experience and relevance by rheumatology fellows and graduates. 
 Fellows   n (%) Graduates   n (%) 
Yes No Yes No 
Prior Education and Experience     
Infusion reaction training/education prior to fellowship 3*  (16.7) 15  (83.3) n/a n/a 
Infusion reaction training/education during fellowship 2†  (11.1) 16  (88.9) 6#  (60) 4  (40) 
Current practice, were you required to complete any training for infusion reaction 
management 
n/a n/a - 10  (100) 
Prior experience working in an infusion clinic with primary role of administering medication - 18  (100) n/a n/a 
During fellowship ever been physically involved in managing an acute infusion reaction 7ⱡ  (38.9) 11  (61.1) n/a n/a 
During fellowship ever been paged regarding a patient having an acute infusion reaction 10  (55.6) 8  (44.4) n/a n/a 
During fellowship, did you ever assess or manage a patient having an acute infusion 
reaction (either in person or by phone) 
n/a n/a 4  (40) 6  (60) 
Since graduation from fellowship, has one of your patients had an acute infusion reaction n/a n/a 2  (22.2) 7  (77.8) 
Since graduation, have you had to assess or manage a patient having an acute infusion 
reaction (either in person or by phone) 
n/a n/a 5**  (50) 5  (50) 
Change a patient’s therapy because of an infusion reaction 11  (61.1) 7  (38.9) n/a n/a 
Has a patient you were treating sustained direct harm, to include death, related to an 
infusion therapy being prescribed 
3§  (16.7) 15  (83.3) n/a n/a 
Relevance     
During fellowship, have you prescribed IV medications for the direct treatment of a 
rheumatic disease 
18  (100) - n/a n/a 
Since graduation from fellowship, have you prescribed IV medications for direct treatment 
of a rheumatic disease 
n/a n/a 9  (90) 1  (10) 
Given the option, do you prefer to prescribe subcutaneous over IV medications 18¶  (100) - 10††  (100) - 
Do you recommend fellows be taught how to manage acute infusion reactions n/a n/a 10  (100) - 
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Table 3.  OSCE checklist results     
 
Rheum Fellow  
Year 1  
n=8 (%) 
Rheum  
Fellow  
Years 2&3  
n=10 (%) 
Combined  
Years  
n=18 (%) 
p-value 
History Taking & Assessment 
   Current vital signs 
   Examination findings 
   Current medications 
   Co-morbidities  
   Onset of symptoms (time) 
   Date of last infusion 
   Prior difficulties with infusion 
   Infusion pre-medications 
   Infusion rate 
   Interventions already completed 
Mean Score (±SD) 
 
5  (62.5) 
7  (87.5) 
1  (12.5) 
1  (12.5) 
1  (12.5) 
5  (62.5) 
4  (50) 
7  (87.5) 
2  (25) 
1  (12.5) 
4.3  (±1.9) 
 
8  (80) 
8  (80) 
2  (20) 
0 
4  (40) 
3  (30) 
2  (20) 
6  (60) 
5  (50) 
1  (10) 
3.9  (±1.7) 
 
13  (72.2) 
15  (83.3) 
3  (16.7) 
1  (5.6) 
5  (27.8) 
8  (44.4) 
6  (33.3) 
13  (72.2) 
7  (38.9) 
2  (11.1) 
4.1  (±1.7) 
 
0.6 
1.0 
1.0 
0.4 
0.3 
0.3 
0.3 
0.3 
0.4 
1.0 
0.7 
Grade 1 Infusion Reaction Management 
   Continue infusion/no change 
   Continue infusion and decrease rate* 
   Discontinue infusion 
   Maintained IV 
   Repeat vital signs 
   Update on patient status with intervention 
Adjunct Medications Recommended 
   Antihistamine 
   Acetaminophen 
Mean Score (±SD) 
 
1  (12.5) 
7  (87.5) 
0 
2  (25) 
8  (100) 
7  (87.5) 
 
7  (87.5) 
0 
3.1  (±0.6) 
 
2  (20) 
8  (80) 
0 
7  (70) 
9  (90) 
8  (80) 
 
8  (80) 
1  (10) 
3.4  (±0.8) 
 
3  (16.7) 
15  (83.3) 
0 
9  (50) 
17  (94.4) 
15  (83.3) 
 
15  (83.3) 
1  (5.6) 
3.3  (±0.8) 
 
1.0 
1.0 
1.0 
0.1 
1.0 
1.0 
 
1.0 
1.0 
0.4 
Grade 4 Infusion Reaction Management     
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   Discontinue infusion 
   Activate emergency response system 
   Continuous non-invasive hemodynamic monitoring 
   Placed patient on oxygen 
   Response to interventions 
   Rituximab placed on patient’s allergy list 
   Transition of care with EMS/ED provider 
   Updated patient’s emergency contact 
   Contacted prescribing rheumatology provider 
Adjunct Medications Recommended 
   Epinephrine 
   Steroids 
   Antihistamine 
   IV Fluids 
   Nebulizer/Albuterol 
   Acetaminophen 
Mean Score (±SD) 
8  (100) 
7  (87.5) 
6  (75) 
4  (50) 
2  (25) 
0 
1  (12.5) 
0 
0 
 
5  (62.5) 
6  (75) 
5  (62.5) 
5  (62.5) 
1  (12.5) 
3  (37.5) 
4.1  (±1.1) 
10  (100) 
7  (70) 
6  (60) 
4  (40) 
5  (50) 
0 
5  (50) 
3  (30) 
0 
 
5  (50) 
7  (70) 
5  (50) 
5  (50) 
2  (20) 
4  (40) 
4.5  (±1.5) 
18  (100) 
14  (77.8) 
12  (66.7) 
8  (44.4) 
7  (38.9) 
0 
6  (33.3) 
3  (16.7) 
0 
 
10  (55.6) 
13  (72.2) 
10  (55.6) 
10  (55.6) 
3  (16.7) 
7  (38.9) 
4.3  (±1.3) 
1.0 
0.6 
0.6 
1.0 
0.4 
1.0 
0.2 
0.2 
1.0 
 
0.7 
1.0 
0.7 
0.7 
1.0 
1.0 
0.6 
Total Mean Score (±SD) 11.5  (±1.4) 11.8  (±1.4) 11.7  (±1.4) 0.8 
     
